These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 8901377)

  • 21. Psychometric Validation of the Bahasa Malaysia Version of the EORTC QLQ-CR29.
    Magaji BA; Moy FM; Roslani AC; Law CW; Raduan F; Sagap I
    Asian Pac J Cancer Prev; 2015; 16(18):8101-5. PubMed ID: 26745045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer.
    Kobayashi K; Takeda F; Teramukai S; Gotoh I; Sakai H; Yoneda S; Noguchi Y; Ogasawara H; Yoshida K
    Eur J Cancer; 1998 May; 34(6):810-5. PubMed ID: 9797690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health related quality of life in stem cell transplantation: clinical and psychometric validation of the questionnaire module, High Dose Chemotherapy (HDC-19).
    Andersson I; Hjermstad M; Stockelberg D; Persson LO
    Acta Oncol; 2008; 47(2):275-85. PubMed ID: 18210301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of disease burden on health-related quality of life in patients with malignant gliomas.
    Osoba D; Brada M; Prados MD; Yung WK
    Neuro Oncol; 2000 Oct; 2(4):221-8. PubMed ID: 11265231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module.
    Paradowska D; Bereza K; Sanna B; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Skotnicki P; Bottomley A; Tomaszewski KA
    Eur J Oncol Nurs; 2017 Aug; 29():148-154. PubMed ID: 28578847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12).
    Weis J; Tomaszewski KA; Hammerlid E; Ignacio Arraras J; Conroy T; Lanceley A; Schmidt H; Wirtz M; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Czeladzki M; Harle A; Jones L; Ritter S; Flechtner HH; Bottomley A;
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.
    Blazeby JM; Conroy T; Hammerlid E; Fayers P; Sezer O; Koller M; Arraras J; Bottomley A; Vickery CW; Etienne PL; Alderson D;
    Eur J Cancer; 2003 Jul; 39(10):1384-94. PubMed ID: 12826041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Validity and reliability of the quality of life questionnaire (EORTC QLQ C30) and its breast cancer module (EORTC QLQ BR23)].
    Zawisza K; Tobiasz-Adamczyk B; Nowak W; Kulig J; Jedrys J
    Ginekol Pol; 2010 Apr; 81(4):262-7. PubMed ID: 20476597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.
    Sprangers MA; Groenvold M; Arraras JI; Franklin J; te Velde A; Muller M; Franzini L; Williams A; de Haes HC; Hopwood P; Cull A; Aaronson NK
    J Clin Oncol; 1996 Oct; 14(10):2756-68. PubMed ID: 8874337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction.
    Winters ZE; Afzal M; Rutherford C; Holzner B; Rumpold G; da Costa Vieira RA; Hartup S; Flitcroft K; Bjelic-Radisic V; Oberguggenberger A; Panouilleres M; Mani M; Catanuto G; Douek M; Kokan J; Sinai P; King MT;
    Br J Surg; 2018 Feb; 105(3):209-222. PubMed ID: 29116657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients.
    Jayasekara H; Rajapaksa LC; Greimel ER
    Psychooncology; 2008 Oct; 17(10):1053-7. PubMed ID: 18203241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients.
    Bjordal K; Kaasa S
    Acta Oncol; 1992; 31(3):311-21. PubMed ID: 1622651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
    Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer.
    Ihn MH; Lee SM; Son IT; Park JT; Oh HK; Kim DW; Kang SB
    Support Care Cancer; 2015 Dec; 23(12):3493-501. PubMed ID: 25824366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of EORTC QLQ-OES18 for Chinese patients with esophageal cancer.
    Dai Z; Lang W; Yang H; Tian J; Sun W; Pekbay B; Lin Y; Wang M; Cui B; Yang S; Li H; Luo L; Guo H; Zhang L
    Dis Esophagus; 2017 Oct; 30(10):1-7. PubMed ID: 28859386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.